The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study.
Steiner, T
The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. [electronic resource] - Cerebrovascular diseases (Basel, Switzerland) - 198-203 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
1015-9770
10.1159/000015851 doi
Aged
Aged, 80 and over
Cerebrovascular Disorders--drug therapy
Europe
Female
Humans
Male
Middle Aged
Plasminogen Activators--adverse effects
Recombinant Proteins--adverse effects
Statistics as Topic
Thrombolytic Therapy--adverse effects
Time Factors
Tissue Plasminogen Activator--adverse effects
The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. [electronic resource] - Cerebrovascular diseases (Basel, Switzerland) - 198-203 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
1015-9770
10.1159/000015851 doi
Aged
Aged, 80 and over
Cerebrovascular Disorders--drug therapy
Europe
Female
Humans
Male
Middle Aged
Plasminogen Activators--adverse effects
Recombinant Proteins--adverse effects
Statistics as Topic
Thrombolytic Therapy--adverse effects
Time Factors
Tissue Plasminogen Activator--adverse effects